We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
26/9/2016 16:10 | Still here,feel btter looking a +% in the tdw a/c.. There must be a bigger sharerice here one day.. I remember selling AHT @34p at breakeven,after their big drop to 2p,averaged it back,,and what is it today, had 20k of them,,to frightened to check,incase I go crackers....gla | abergele | |
26/9/2016 15:50 | Me too Freedosh ... I guess when we were at almost £4 in 2013, i never thought we'd be where we'd be or see what we've seen of the share price this past year! GLA | hugus maximus | |
26/9/2016 15:50 | Yes tightfist I believe that we could save a lot on costs to approval. I just don't want to see RDZ being given away for a lot less than the value I put on it Just hope we are not committed yet to either option at too low a price | freedosh | |
26/9/2016 15:45 | Hi Freedosh,(Apologies if this was covered last week but) I saw your comment about the attractions of keeping RDZ and accepting some dilution. Does last week's news regarding the FDA and Sarepta open the door to a vastly reduced cost of taking ETD to market and hence that a modest dilution might enable retention of both ETD and RDZ? Or could a cash sale of limited RDZ geographic/market rights provide the necessary dosh?Just a thought, tightfist | tightfist | |
26/9/2016 15:36 | Just bought 1k for the sipp as todays' news makes us a target for one of the big boys!!! | joeblogg2 | |
26/9/2016 15:31 | Not selling Hugus. I'm a long term holder for the big prize! | freedosh | |
26/9/2016 15:25 | Approaching our average holding Freedosh .. bring it on. | hugus maximus | |
26/9/2016 15:11 | Decent volume on Nasdaq , equal to 500k shares. Good call Freedosh. Twitter alive with traders talking of SRPT buying us! | waterloo01 | |
26/9/2016 14:52 | The last time we rose like this we 5 bagged in 3 weeks, hope for the same again and then the deal announcement :)) Good luck all | jag63 | |
26/9/2016 14:41 | about bloody time i say ! m | maurillac | |
26/9/2016 14:34 | currently opening on NASDAQ around 20% up! | hugus maximus | |
26/9/2016 14:16 | Make that No. 10 now | freedosh | |
26/9/2016 14:15 | Steadily climbing. Currently No. 16 16 minutes to NAS and potential take off | freedosh | |
26/9/2016 13:25 | abergele If you want to do a little reading, 45 pages, google AMR-Review.org Antibiotics. It's from May this year and will give you the reason I feel we may still be underestimating the potential value of RDZ, and why I would hope any deal done now, would include some sort of clause to make sure SUMM get their fair share of any future world government bounty. | kmjs | |
26/9/2016 12:55 | Snap, Hugus, my break even is also £1.60 so have been heavily under water but relaxed as I look only to the future with total confidence in our portfolio. | freedosh | |
26/9/2016 12:43 | Not sure what parallel health service Hip was working in but let's just take a fairly old orphan disease treatment for (mainly) children as an example. Gauchers enzyme replacement therapy Cerezyme costs around £100k pa. in the NHS. The company has introduced a new version costed at 320k dollars pa albeit in the US. If we show clinical PoP we are likely to clean up since our drug is oral, so far without toxicity, and with low CoGs compared to the gene therapy alternatives. We can come in at say £100k pa , a fraction of the cost of the alternatives Fast track designation will excite the US even more than here, IMO. | freedosh | |
26/9/2016 12:42 | H.M. I agree,I have another 10p at least to get to evens from,£1.50,,an | abergele | |
26/9/2016 12:38 | abergale ... sentiment is looking good but sadly like other investors who have been here for many years, my average is still some way further north. (£1.60 or 8p in long term holders early currency!) | hugus maximus | |
26/9/2016 12:36 | Just watch this fly on the Nasdac this afternoon,,seatbelts fastened,and waiting..gla..we should/could see further moves in a response perhaps. | abergele | |
26/9/2016 12:28 | We have gained over 50% in a week,,jolly nice for us holders, but better still for the use of the drugs against these dire illneses out there. | abergele | |
26/9/2016 12:24 | Well done waterloo01 & thanks for the post.It looks like the markets like the RNS currently up 16.5 (12.84%). | chrisatrdg | |
26/9/2016 12:21 | Thanks Waterloo and Freedosh,nice explanation for me I must say,and echo your thoughts.... Yes we have been fortunate these past days ,so we can perhaps relax a little with our investments by all,does make you feel happy on a wet day here....gla | abergele |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions